Denmark has become the first country to stop using AstraZeneca’s COVID-19 vaccine altogether.
- The health authorities cited the news of vaccine’s possible link to very rare blood clot Cerebral venous sinus thrombosis (CVST) disease.
- The U.S. also announced on April 13 that they are recommending a “pause” of single-dose Johnson & Johnson COVID-19 vaccines from being administered as they investigate “extremely rate” blood clot reports.
- The European Union’s drug watchdog had also found a possible link between the AstraZeneca vaccine and cerebral venous sinus thrombosis (CVST), but said the risk of dying from COVID-19 was “much greater” than the risk of mortality from rare side effects.
- According to the John Hopkins Medicine, cerebral venous sinus thrombosis (CVST) occurs when a blood clot forms in the brain’s venous sinuses. This prevents blood from draining out of the brain. As a result, blood cells may break and leak blood into the brain tissues, forming a hemorrhage.
